Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 11, 2011 - Issue 5
Submit an article Journal homepage
215
Views
39
CrossRef citations to date
0
Altmetric
Theme: Alzheimer's disease - Review

Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia

Geoffrey A Kerchner Stanford Center for Memory Disorders, Stanford University Medical Center, 300 Pasteur Drive, Room A343, Stanford, CA 94305-5235, USA. [email protected]; Stanford Center for Memory Disorders, Stanford University Medical Center, 300 Pasteur Drive, Room A343, Stanford, CA 94305-5235, USA. [email protected]
,
Maria Carmela Tartaglia UCSF Memory and Aging Center, University of California, CA, USA; UCSF Memory and Aging Center, University of California, CA, USA
&
Adam L Boxer UCSF Memory and Aging Center, University of California, CA, USA; UCSF Memory and Aging Center, University of California, CA, USA
Pages 709-717 | Published online: 09 Jan 2014

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lyndsey Nickels & Karen Croot. (2014) Understanding and living with primary progressive aphasia: Current progress and challenges for the future. Aphasiology 28:8-9, pages 885-899.
Read now
Michał Harciarek, Dolores Malaspina, Tao Sun & Elkhonon Goldberg. (2013) Schizophrenia and frontotemporal dementia: Shared causation?. International Review of Psychiatry 25:2, pages 168-177.
Read now

Articles from other publishers (37)

Mario F. Mendez & Imaad Nasir. (2023) Distinguishing Semantic Variant Primary Progressive Aphasia from Alzheimer’s Disease. Journal of Alzheimer's Disease Reports 7:1, pages 227-234.
Crossref
A. Mouton, A. Plonka, R. Fabre, T. M. Tran, P. Robert, J. Macoir, V. Manera & A. Gros. (2022) The course of primary progressive aphasia diagnosis: a cross-sectional study. Alzheimer's Research & Therapy 14:1.
Crossref
Olivia Herrmann, Bronte Ficek, Kimberly T Webster, Constantine Frangakis, Adam P Spira & Kyrana Tsapkini. (2022) Sleep as a predictor of tDCS and language therapy outcomes. Sleep 45:3.
Crossref
Nathan Herrmann, Zahinoor Ismail, Rhonda Collins, Philippe Desmarais, Zahra Goodarzi, Alexandre Henri‐Bhargava, Andrea Iaboni, Julia Kirkham, Fadi Massoud, Andrea Moser, James Silvius, Jennifer Watt & Dallas Seitz. (2022) CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia. Alzheimer's & Dementia: Translational Research & Clinical Interventions 8:1.
Crossref
Rita Khoury, Yu Liu, Quratulanne Sheheryar & George T. Grossberg. (2021) Pharmacotherapy for Frontotemporal Dementia. CNS Drugs 35:4, pages 425-438.
Crossref
Peter A. Ljubenkov & Adam L. Boxer. 2021. Frontotemporal Dementias. Frontotemporal Dementias 297 310 .
Laura C. Maclagan, Susan E. Bronskill, Michael A. Campitelli, Shenzhen Yao, Christoffer Dharma, David B. Hogan, Nathan Herrmann, Joseph E. Amuah & Colleen J. Maxwell. (2020) Resident-Level Predictors of Dementia Pharmacotherapy at Long-Term Care Admission: The Impact of Different Drug Reimbursement Policies in Ontario and Saskatchewan: Prédicteurs de la pharmacothérapie de la démence au niveau des résidents lors de l’hospitalisation dans des soins de longue durée : l’impact de différentes politiques de remboursement des médicaments en Ontario et en Saskatchewan. The Canadian Journal of Psychiatry 65:11, pages 790-801.
Crossref
Rita Guerreiro, Elizabeth Gibbons, Miguel Tábuas-Pereira, Celia Kun-Rodrigues, Gustavo C. Santo & Jose Bras. (2020) Genetic architecture of common non-Alzheimer’s disease dementias. Neurobiology of Disease 142, pages 104946.
Crossref
Marta Kowalska, Katarzyna Wize, Michał Prendecki, Margarita Lianeri, Wojciech Kozubski & Jolanta Dorszewska. (2020) Genetic Variants and Oxidative Stress in Alzheimer’s Disease. Current Alzheimer Research 17:3, pages 208-223.
Crossref
Shan Hui Lai, Tung Tsoi, Chao Tian Tang, Richard Jor Yeong Hui, Kim Kiat Tan, Yehudi Wee Shung Yeo & Ee Heok Kua. (2019) An integrated, collaborative healthcare model for the early diagnosis and management of dementia: Preliminary audit results from the first transdisciplinary service integrating family medicine and geriatric psychiatry services to the heart of patients’ homes. BMC Psychiatry 19:1.
Crossref
Armin von Gunten, Eduardo Nogueira, Henk Parmentier & Irênio Gomes. 2019. Primary Care Mental Health in Older People. Primary Care Mental Health in Older People 251 298 .
Biswa Ranjan Mishra, Vanteemar S. Sreeraj, Saranya Dhanashekaran & Rituparna Maiti. (2018) Donepezil for Compulsive Behavior in Degenerative Dementia: Case Series. Clinical Psychopharmacology and Neuroscience 16:2, pages 224-227.
Crossref
Peter van Domburg, Femke Deguelle, Yvonne Raaijmakers, Susan Slot & Sander Jentjens. (2018) Taalstoornissen bij dementie deel 1: primair progressieve afasie. Neuropraxis 22:1, pages 2-15.
Crossref
HyunChul Youn & Hyun-Ghang Jeong. (2018) Pharmacotherapy for dementia. Journal of the Korean Medical Association 61:12, pages 758.
Crossref
Corinne E. Fischer, Winnie Qian, Tom A. Schweizer, Zahinoor Ismail, Eric E. Smith, Colleen P. Millikin & David G. Munoz. (2017) Determining the impact of psychosis on rates of false-positive and false-negative diagnosis in Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions 3:3, pages 385-392.
Crossref
Massimiliano Buoli, Marta Serati, Alice Caldiroli, Daniela Galimberti, Elio Scarpini & Alfredo Carlo Altamura. (2017) Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review. Journal of Geriatric Psychiatry and Neurology 30:3, pages 162-169.
Crossref
Eline Wauters, Kristel Sleegers, Marc Cruts & Christine Van Broeckhoven. 2017. Disease-Modifying Targets in Neurodegenerative Disorders. Disease-Modifying Targets in Neurodegenerative Disorders 199 249 .
Gabriel C. Léger. 2017. Neuro-Geriatrics. Neuro-Geriatrics 103 124 .
Florence Pasquier, Thibaud Lebouvier & Florence Lebert. 2017. Neuropsychiatric Symptoms of Cognitive Impairment and Dementia. Neuropsychiatric Symptoms of Cognitive Impairment and Dementia 279 302 .
Ruth Lamb, Jonathan D. Rohrer, Andrew J. Lees & Huw R. Morris. (2016) Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options. Current Treatment Options in Neurology 18:9.
Crossref
Sarah J. DeLozier & Deana Davalos. (2016) A Systematic Review of Metacognitive Differences Between Alzheimer’s Disease and Frontotemporal Dementia. American Journal of Alzheimer's Disease & Other Dementiasr 31:5, pages 381-388.
Crossref
Chit Wai Wong. (2016) Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine. Drugs & Aging 33:7, pages 451-460.
Crossref
Edward D. Huey & Masood Manoochehri. 2016. Hodges' Frontotemporal Dementia. Hodges' Frontotemporal Dementia 229 242 .
. 2016. Hodges' Frontotemporal Dementia. Hodges' Frontotemporal Dementia 211 271 .
Craig A. Hunter, Noam Y. Kirson, Urvi Desai, Alice Kate G. Cummings, Douglas E. Faries & Howard G. Birnbaum. (2015) Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries. Alzheimer's & Dementia 11:8, pages 887-895.
Crossref
Michael R Misch, Sara Mitchell, Philip L Francis, Kayla Sherborn, Katayoun Meradje, Alicia A McNeely, Kie Honjo, Jiali Zhao, Christopher JM Scott, Curtis B Caldwell, Lisa Ehrlich, Prathiba Shammi, Bradley J MacIntosh, Juan M Bilbao, Anthony E Lang, Sandra E Black & Mario Masellis. (2014) Differentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomography. Alzheimer's Research & Therapy 6:9.
Crossref
Maria Carmela Tartaglia, Bei Hu, Kala Mehta, John Neuhaus, Kristine Yaffe, Bruce L. Miller & Adam Boxer. (2014) Demographic and Neuropsychiatric Factors Associated With Off-label Medication Use in Frontotemporal Dementia and Alzheimer’s Disease. Alzheimer Disease & Associated Disorders 28:2, pages 182-189.
Crossref
Zdenek RohanRadoslav Matej. (2014) Current Concepts in the Classification and Diagnosis of Frontotemporal Lobar Degenerations: A Practical Approach. Archives of Pathology & Laboratory Medicine 138:1, pages 132-138.
Crossref
Kelly Cho, David R. Gagnon, Jane A. Driver, Arman Altincatal, Nicole Kosik, Stephan Lanes & Elizabeth V. Lawler. (2014) Dementia Coding, Workup, and Treatment in the VA New England Healthcare System. International Journal of Alzheimer's Disease 2014, pages 1-5.
Crossref
Brian P. Gomoll, Brandon D. Sanders & Maria T. Caserta. (2014) Psychopharmacologic Treatments for Alzheimer Disease and Related Dementias. Psychopharm Review 49:1, pages 9-16.
Crossref
Joseph E Gaugler, Haya Ascher-Svanum, David L Roth, Tolulope Fafowora, Andrew Siderowf & Thomas G Beach. (2013) Characteristics of patients misdiagnosed with Alzheimer’s disease and their medication use: an analysis of the NACC-UDS database. BMC Geriatrics 13:1.
Crossref
Dantao Peng, Xinrui Yuan & Rui Zhu. (2013) Memantine hydrochloride in the treatment of dementia subtypes. Journal of Clinical Neuroscience 20:11, pages 1482-1485.
Crossref
Benedetto Falsini, Ronald A. Bush & Paul A. Sieving. 2013. Retina. Retina 716 733 .
Trevor Archer & Boo Johansson. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine 289 308 .
Christopher M. Wittich, Christopher M. Burkle & William L. Lanier. (2012) Ten Common Questions (and Their Answers) About Off-label Drug Use. Mayo Clinic Proceedings 87:10, pages 982-990.
Crossref
Masood Manoochehri & Edward D. Huey. (2012) Diagnosis and Management of Behavioral Issues in Frontotemporal Dementia. Current Neurology and Neuroscience Reports 12:5, pages 528-536.
Crossref
Abhilash K. Desai, Lori Schwartz & George T. Grossberg. (2012) Behavioral Disturbance in Dementia. Current Psychiatry Reports 14:4, pages 298-309.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.